SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- UN Security Council Extends Mandate Of Peacekeeping Force On Golan Heights
- Leader Of Colombian Criminal Ring Captured In UAE, Says Ecuador’s Interior Minister
- Egypt’s FM Discusses Iranian Nuclear Issue With Iran’s FM, IAEA Chief
- Two Rockets Hit Airbase Area In N. Iraq
- Israeli Airstrike On Gaza Beachfront Cafe Kills At Least 34; Total Death Toll: 56,531+
- S. Korea’s Top Prosecutor Offers To Resign
- Gunmen Shot Dead Four In India’s Manipur
- Iran Says U.S. “Betrayed” Diplomacy By “Encouraging” Israeli Attacks
- 71 Killed In Israeli Strike On Prison In Tehran: Iran’s Judiciary
- Iran’s Top Military Commander Questions Israel’s Ceasefire Commitment